Market Tracker

06/29 2:16pm ET
15.85
BATS BZX Real-Time Price
As of 2:14pm ET
 +0.37 / +2.39%
Today’s Change
14.07
Today|||52-Week Range
18.04
-2.16%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close15.48
Today’s open16.10
Day’s range15.84 - 16.20
Volume44,184
Average volume (3 months)1,392,164
Market cap$4.0B
Dividend yield2.24%
Data as of 2:14pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.80%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+1.21+2.76%
ICPTIntercept Pharmaceut...-1.08-0.72%
ENDPEndo International P...+0.07+0.43%
ACADACADIA Pharmaceutica...+0.87+2.75%
Data as of 2:16pm ET, 06/29/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
VĂ­ctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts